| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 9x4 | MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-yn-1-yl)-6,7-dihydro-5H-5,7-methanobenzo[c]imidazo[1,2-a]azepine-2,3-dicarboxamide) | 5w5q | 95.36 |
| 2 | 3c8 | MAP4K4 T181E Mutant Bound to inhibitor compound 1 | 4u42 | 94.43 |
| 3 | 3c8 | MAP4K4 Bound to inhibitor compound 1 | 4u41 | 93.78 |
| 4 | 3d8 | MAP4K4 in complex with inhibitor (compound 6) | 4u43 | 93.76 |
| 5 | 5df | MAP4K4 in complex with an inhibitor | 5di1 | 89.58 |
| 6 | 3dc | MAP4K4 in complex with inhibitor (compound 25) | 4u45 | 87.42 |
| 7 | 3d9 | MAP4K4 in complex with inhibitor (compound 16) | 4u44 | 86.55 |
| 8 | 3xm | MAP4K4 in complex with a pyridin-2(1H)-one derivative | 4rvt | 85.19 |
| 9 | 4p4 | MAP4K4 in complex with inhibitor GNE-495 | 4zk5 | 83.35 |
| 10 | 6hh | MAP4K4 in complex with inhibitor | 5j95 | 81.8 |
| 11 | 2qt | MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PYRROLIDIN-1-YL)ACETAMIDE | 4obq | 79.09 |